MD Anderson names chief quality and value officer
Click Here to Manage Email Alerts
Kerin Adelson, MD, has been named chief quality and value officer at The University of Texas MD Anderson Cancer Center.
In this role, she will help lead medical practice quality improvement efforts and value-based care initiatives to support the institution’s strategy. She also will guide initiatives intended to optimize the cost and quality of patient care and demonstrate value to insurers.
Adelson also will hold a faculty appointment in breast medical oncology.
“As we continue to advance our mission to end cancer, we are committed to improving the lives of our patients and their families. Central to that is our strategic focus on high-touch, high-value cancer care,” Peter WT Pisters, MD, president of MD Anderson, said in a press release. “Dr. Adelson brings tremendous experience and insightful leadership that will help us to advance our efforts in this space and ensure optimal, value-based care for all patients.”
Adelson served as chief quality officer and deputy chief medical officer at Yale Cancer Center and Smilow Cancer Hospital since 2014. She has served as investigator on several clinical trials for early-stage and metastatic disease, and she also has published clinical research related to end-of-life care, clinical care redesign and new models of value-based care.
“As one of the world’s most respected cancer centers, MD Anderson has an unparalleled opportunity to impact cancer care delivery on a national and international level,” Adelson said in the release. “I am tremendously excited to join this stellar community and partner with world-renowned clinicians and scientists to advance MD Anderson’s strategic vision and mission.”
Click Here to Manage Email Alerts